Can't say I disagree, but management are very frugal on announcements unless there's an legal obligation.
I would love for the sales report to be mind blowing but if it's not it's just a matter of time. The best product for a significant medical issue cannot fail IMO, especially with an experienced team at the helm.
I suspect there's some artificial price manipulation designed to get shares out of the hands of retail investors before the push upwards but I'm willing to admit that's part wishful thinking
BOT Price at posting:
29.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)